Duke startup focused on treating depression falls short of fundraising goal


A Duke startup working to develop a treatment for depression has brought in close to $2 million, but has fallen well short of its target.

Previous A cash strategy sounds unexciting, but it is important to a business’ success
Next Five things you need to know today, and can you name that hospital system?